We have heard lots of information lately about talcum powder use and the risk of ovarian cancer. Let’s step back and look at the facts.
Ovarian Cancer
“Initially, ovarian cancer, melanoma, and some sarcomas are the three main targets,” says Dr. Koya, “but the clinical trial is open for patients with other cancers who meet the eligibility requirements."
Collected last week from a patient with late-stage ovarian cancer, these are not ordinary T cells; they have been altered and multiplied in the hope that when they are given back to her, they will launch a devastating attack on her cancer cells.
While an estimated 5 to 10 percent of all cancers are due to hereditary factors, ovarian cancer is unique—up to 25 percent of these cancers are thought to have a hereditary cause.
Growing up as the daughter of two physicians in Budapest, Hungary, Emese Zsiros, MD, PhD, FACOG, recognized her passion for medicine at an early age. She earned a combined MD/PhD at one of the top medical schools in Europe before heading to the United States to complete her OB/GYN residency.